Prognosis and Neutrophil-to-Lymphocyte Ratio in Nivolumab-treated Patients with Recurrent/Metastatic Head and Neck Cancer
2020 ◽
Vol 106
(5)
◽
pp. 1174
Keyword(s):
2020 ◽
2015 ◽
Vol 59
(4)
◽
pp. 514-519
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 11
(3)
◽
pp. 417-422
◽
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. 6038-6038
◽
Keyword(s):
Keyword(s):